IBIO Stock Analysis: Buy, Sell, or Hold?

IBIO - iBio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.10
-0.05 (-2.33%) ▼
5d: -6.67%
30d: +22.81%
90d: +36.36%
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 09, 2026 6d

Get Alerted When IBIO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: IBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: IBIO is currently trading at $2.10, which is considered fair relative to its 30-day fair value range of $1.92 to $2.42.

Technical Outlook: Technically, IBIO is in a strong uptrend. The price is currently testing key support at $2.06. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.72 (+124.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Fair Price Range $1.92 - $2.42
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 124.8% below Wall St target ($4.72)
  • CAUTION: Recommendation downgraded due to -6.7% 5-day decline

Fair Price Analysis

30-Day Fair Range $1.92 - $2.42
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $2.06
Resistance Level $2.47
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -6.63
Wall Street Target $4.72 (+124.8%)
Revenue Growth (YoY) 14.3%
Last updated: February 02, 2026 1:50 AM ET
Data refreshes hourly during market hours. Next update: 2:50 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$66 46 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$117 59 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$112 52 HOLD
RNA
Avidity Biosciences Inc
STRONG BUY
15 analysts
$75 62 BUY
DNTH
Dianthus Therapeutics In…
STRONG BUY
12 analysts
$71 60 HOLD

More Analysis for IBIO

IBIO Technical Chart IBIO Price Prediction IBIO Earnings Date IBIO Investment Advisor IBIO Fair Price Analyzer IBIO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals